 CohBar, Inc. CWBR, a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will release its first quarter 2020 financial results after the market closes on Thursday, May 14, 2020. Management will host a conference call with a slide presentation at 5:00 p.m. ET 2:00 p.m. PT on the same day to provide an update on the companys business. 